Abstract
Opinion statement: Well differentiated thyroid carcinoma (WDTC) is a relatively common malignancy accounting for an estimated 37,000 thousand cases in the United States in 2009 [1]. WDTC also has a generally high 5 year survival rate that correlates with age. Papillary thyroid carcinoma (PTC) greater than 1 cm is best managed by total thyroidectomy. Thyroid lobectomy and isthmusectomy may be adequate for unifocal PTC less than 1 cm in patients without negative prognostic factors. Central compartment and possible lateral neck dissections should be performed when nodal metastases are present in the respective nodal basins. Post-operatively, radioactive iodine ablation with 131I followed by thyroid stimulating hormone (TSH) suppression is indicated in certain patients to improve locoregional control and reduce recurrence.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 47-57 |
| Number of pages | 11 |
| Journal | Current Treatment Options in Oncology |
| Volume | 13 |
| Issue number | 1 |
| DOIs | |
| State | Published - Mar 1 2012 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Papillary thyroid cancer
- Thyroglobulin
- Thyroid cancer
- Thyroidectomy
ASJC Scopus subject areas
- Oncology
- Pharmacology (medical)
Fingerprint
Dive into the research topics of 'Well differentiated thyroid carcinoma: Current treatment'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS